STOCK TITAN

Hillenbrand, Inc. Form 4 Filings

HI NYSE

Every Form 4 that Hillenbrand, Inc. (HI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow HI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HI filings page.

Rhea-AI Summary

Hillenbrand, Inc. director Inderpreet Sawhney reported automatic equity disposition tied to the company’s merger with LSF12 Helix Parent, LLC. On February 10, 2026, Merger Sub combined with Hillenbrand, leaving Hillenbrand as a wholly owned subsidiary of Parent.

At the effective time of the merger, each share of Hillenbrand common stock was converted into the right to receive $32.00 in cash per share. Each time-vesting restricted stock unit and each vested deferred share was cancelled in exchange for a cash payment equal to the number of underlying shares multiplied by the $32.00 merger consideration, less required tax withholding. The filing also notes this amendment withdraws a prior Form 4 that contained incorrect data.

Rhea-AI Summary

Hillenbrand, Inc. director Jennifer Rumsey reported the cash-out of her equity in connection with the company’s merger with LSF12 Helix Parent, LLC. At the merger’s effective time, each share of common stock was converted into the right to receive $32.00 in cash, without interest.

Rumsey’s 16,901 restricted stock units, each representing one share of common stock, were cancelled and converted into a cash payment based on the $32.00 per-share merger consideration, less taxes. In addition, 587 common shares held indirectly through The Revocable Living Trust Agreement Jennifer W. Rumsey were likewise converted into the right to receive the same cash consideration per share.

Rhea-AI Summary

Hillenbrand, Inc. completed its merger with LSF12 Helix Parent, LLC, with Merger Sub combining into the company so it became a wholly owned subsidiary of Parent. At the effective time, each share of common stock was converted into the right to receive $32.00 in cash, without interest.

The Form 4 shows Sr. VP & Chief HR Officer Aneesha Arora had common shares, including shares held indirectly through The Arora Revocable Trust, and restricted stock units cancelled in connection with the merger in exchange for cash based on the $32.00 merger consideration, leaving no remaining equity holdings reported.

Rhea-AI Summary

Hillenbrand, Inc. filed a Form 4 showing its director Inderpreet Sawhney’s equity awards were cashed out in a completed merger. On February 10, 2026, a merger closed in which an affiliate of LSF12 Helix Parent, LLC acquired Hillenbrand, with each share of common stock converted into the right to receive $32.00 in cash.

As a result, 16,901 restricted stock units held by the director were cancelled in exchange for a cash payment based on the merger consideration, less withholding taxes. In a separate transaction, 587 shares of common stock held indirectly through The Revocable Living Trust Agreement Jennifer W. Rumsey were also converted into the cash merger consideration, leaving the director reporting zero shares and units beneficially owned.

Rhea-AI Summary

Hillenbrand, Inc. director Neil S. Novich reported the cash-out of his equity awards in connection with the company’s merger with LSF12 Helix Parent, LLC. At the merger’s effective time, each share of common stock was converted into the right to receive $32.00 in cash.

Novich’s 67,968 restricted stock units, each representing one share of common stock, were cancelled and exchanged for a cash payment based on the $32.00 per-share merger consideration, less required withholding taxes. Following this transaction, he reported zero derivative securities beneficially owned.

Rhea-AI Summary

Hillenbrand, Inc. completed a cash merger in which all common shares and equity awards were converted into cash at $32.00 per share. LSF12 Helix Merger Sub merged into Hillenbrand, which now operates as a wholly owned subsidiary of LSF12 Helix Parent, LLC.

For Sr. VP & President, APS, Bartel Ulrich, 29,508 shares of common stock and 45,503 restricted stock units were cancelled in connection with the merger, with each underlying share converted into the right to receive the $32.00 cash merger consideration, less applicable withholding taxes.

Rhea-AI Summary

Hillenbrand, Inc. President and CEO Kimberly K. Ryan reported the cash-out of her company equity in connection with the closing of a merger. On February 10, 2026, LSF12 Helix Merger Sub, Inc. merged with Hillenbrand, with Hillenbrand surviving as a wholly owned subsidiary of LSF12 Helix Parent, LLC.

At the effective time of the merger, each share of Hillenbrand common stock was converted into the right to receive $32.00 in cash, without interest. Ryan reported the disposition of 208,945.745 shares of common stock, as well as the cancellation of 271,486 restricted stock units and 42,728 stock options, each in exchange for cash payments calculated using the $32.00 per-share merger consideration, less applicable withholding taxes.

Rhea-AI Summary

Hillenbrand, Inc. director reports cash-out of equity awards after merger

Director Dennis W. Pullin reported the disposition of 14,361 restricted stock units on February 10, 2026. These units were cancelled in connection with the closing of a merger in which LSF12 Helix Merger Sub, Inc. merged into Hillenbrand, Inc., making Hillenbrand a wholly owned subsidiary of LSF12 Helix Parent, LLC.

At the merger’s effective time, each share of Hillenbrand common stock was converted into the right to receive $32.00 in cash, and each time-vesting or deferred restricted stock unit was cancelled for a cash payment based on the number of underlying shares multiplied by the $32.00 merger consideration, less applicable tax withholding. Following the transaction, Pullin reported beneficial ownership of zero derivative securities.

Rhea-AI Summary

Hillenbrand, Inc. completed a merger in which LSF12 Helix Merger Sub, Inc. merged into Hillenbrand, making it a wholly owned subsidiary of LSF12 Helix Parent, LLC. At the effective time, each share of Hillenbrand common stock was converted into the right to receive $32.00 in cash, without interest, subject to limited exceptions.

For Sr. VP, GC & Secretary Nicholas R. Farrell, 74,792 shares of common stock were disposed of, while 38,288 shares were acquired and then disposed of the same day under the merger mechanics. In addition, 57,987 restricted stock units and 22,621 stock options were cancelled in exchange for cash amounts calculated using the $32.00 merger consideration, less applicable withholding taxes.

Rhea-AI Summary

Hillenbrand, Inc. director Stuart A. Taylor II reported the cash-out of his equity awards in connection with the company’s merger with LSF12 Helix Parent, LLC. On February 10, 2026, Merger Sub combined with Hillenbrand, which became a wholly owned subsidiary of Parent.

At the effective time of the merger, each share of Hillenbrand common stock was converted into the right to receive $32.00 in cash, without interest, subject to certain exceptions. Taylor’s 87,756 restricted stock units, each representing one share of common stock, were cancelled and converted into a cash payment based on the $32.00 merger consideration per underlying share, less required withholding taxes, leaving him with 0 derivative securities reported after the transaction.

Rhea-AI Summary

Hillenbrand, Inc. insider Megan A. Walke, Interim CFO, VP, CC, & CAO, reported equity changes tied to the company’s cash merger with LSF12 Helix Parent, LLC. On February 10, 2026, each share of Hillenbrand common stock outstanding was converted into the right to receive $32.00 in cash, with the company becoming a wholly owned subsidiary of the buyer.

In connection with the merger, Walke’s 6,423 shares of common stock were disposed of, and 10,280 restricted stock units were cancelled, all in exchange for cash based on the $32.00 per-share merger consideration, less applicable taxes. Time-based and performance-based restricted stock units were similarly cancelled for cash according to their underlying share counts.

Rhea-AI Summary

Hillenbrand, Inc. director Joseph T. Lower reported the cash-out of his equity in connection with the company’s merger with LSF12 Helix Parent, LLC. On February 10, 2026, Merger Sub combined with Hillenbrand, which survived as a wholly owned subsidiary of Parent.

At the merger’s effective time, each share of Hillenbrand common stock was converted into the right to receive $32.00 in cash, without interest. Lower’s 79 shares of common stock and 4,151 restricted stock units, each representing one share of common stock, were cancelled and converted into cash based on the $32.00 per-share merger consideration, leaving him with zero shares and zero derivative securities beneficially owned.

Rhea-AI Summary

Hillenbrand, Inc. director Joy M. Greenway reported the cancellation of 45,733 restricted stock units on February 10, 2026 in connection with the closing of a merger. At the effective time of the merger, each share of Hillenbrand common stock was converted into the right to receive $32.00 in cash.

Each restricted stock unit represented the right to receive one share of common stock. All of Greenway’s time-vesting restricted stock units and vested deferred shares were cancelled and converted into a cash payment based on the $32.00 merger consideration per underlying share, less applicable withholding taxes, leaving 0 derivative securities owned after the transaction.

Rhea-AI Summary

Hillenbrand, Inc. executive Tamara Morytko reported the cash-out of her equity in connection with the company’s sale to LSF12 Helix Parent, LLC. On February 10, 2026, Hillenbrand completed a merger in which it became a wholly owned subsidiary of LSF12 Helix Parent.

At the merger’s effective time, each share of Hillenbrand common stock was converted into the right to receive $32.00 in cash, without interest. Morytko’s directly held common shares were converted on these terms, eliminating her post‑transaction common stock holdings.

Morytko also reported the cancellation of 55,941 restricted stock units, each representing one share of common stock. These awards were canceled in exchange for cash equal to the number of underlying shares multiplied by the $32.00 merger price, less applicable withholding taxes.

Rhea-AI Summary

Hillenbrand, Inc. director Helen W. Cornell reported the automatic cancellation and cash-out of equity awards and shares in connection with the company’s merger. On February 10, 2026, Hillenbrand merged with a subsidiary of LSF12 Helix Parent, LLC and became its wholly owned subsidiary.

At the merger’s effective time, each share of Hillenbrand common stock was converted into the right to receive $32.00 in cash, without interest. Cornell reported the disposition of 61,056 restricted stock units, each tied to one share of common stock, and 13,191 common shares held indirectly through the Helen W. Cornell 2020 Irrevocable Trust and the Helen W. Cornell Revocable Trust, all resulting in cash consideration instead of ongoing equity ownership.

Rhea-AI Summary

Hillenbrand, Inc. senior vice president and chief procurement officer Carole Anne Phillips reported equity transactions tied to the company’s go-private merger with LSF12 Helix Parent, LLC. On February 10, 2026, each share of Hillenbrand common stock was converted into the right to receive $32.00 in cash under the merger agreement.

Phillips reported the disposition of common shares and the cancellation of 16,607 restricted stock units, which each represented the right to receive one share of common stock. Both time‑ and performance‑based restricted stock units were cancelled at the merger’s effective time in exchange for cash based on the $32.00 per share merger consideration, less any required tax withholding.

Rhea-AI Summary

Hillenbrand, Inc. director Inderpreet Sawhney reported the cash-out of equity awards tied to the company’s merger. On February 10, 2026, all 14,027 restricted stock units were disposed of, leaving zero derivative securities owned directly. This followed the closing of Hillenbrand’s merger with LSF12 Helix Parent, LLC.

At the merger’s effective time, each share of Hillenbrand common stock was converted into the right to receive $32.00 in cash. Each time‑vesting restricted stock unit and vested deferred share was cancelled in exchange for a cash payment based on the number of shares underlying the award multiplied by the $32.00 merger consideration, less withholding taxes.

Rhea-AI Summary

Hillenbrand, Inc. completed a merger in which it became a wholly owned subsidiary of LSF12 Helix Parent, LLC. At the effective time, each share of common stock was converted into the right to receive $32.00 in cash, without interest.

In connection with this merger, Sr. VP of Strategy & Corporate Development J. Michael Whitted had 88,349 shares of common stock and 94,730 restricted stock units canceled for cash based on the $32.00 merger price, less taxes. In addition, 11,729 stock options with a per-share exercise price below $32.00 were canceled for a cash payment equal to the spread between $32.00 and the option exercise price.

Rhea-AI Summary

Hillenbrand, Inc. completed a merger in which LSF12 Helix Merger Sub, Inc. combined with the company, making Hillenbrand a wholly owned subsidiary of LSF12 Helix Parent, LLC. At the merger’s effective time, each share of common stock was converted into the right to receive $32.00 in cash.

For Sr. VP & Chief Information Officer Bhavik N. Soni, 15,597 shares of common stock, 18,683 restricted stock units, and 7,540 stock options were reported as disposed or cancelled on February 10, 2026. These equity awards were converted into cash payments based on the merger consideration, subject to applicable withholding taxes.

Rhea-AI Summary

Hillenbrand, Inc. director Daniel C. Hillenbrand reported the automatic disposition of his equity holdings in connection with the company’s merger with LSF12 Helix Parent, LLC. At the merger’s effective time, each share of common stock was converted into the right to receive $32.00 in cash.

The filing shows 3,448 shares of common stock held directly and several indirect positions, including 135,863 shares held by Clear Water Capital Partners, LP, all disposed of in the transaction. In addition, 24,786 restricted stock units were cancelled and cashed out based on the $32.00 merger consideration, subject to applicable tax withholding.

Rhea-AI Summary

Hillenbrand, Inc. director Gary L. Collar reported the cancellation of 36,501 restricted stock units on February 10, 2026 in connection with the closing of a cash merger. After this transaction, he held 0 derivative securities directly.

Under the merger, an affiliate of LSF12 Helix Parent, LLC combined with Hillenbrand, which continued as a wholly owned subsidiary. Each Hillenbrand common share outstanding immediately before the effective time was converted into the right to receive $32.00 in cash, and each company restricted stock unit, whether vested or unvested, was cancelled for a cash payment based on the $32.00 merger consideration per underlying share, less applicable taxes.

Rhea-AI Summary

Hillenbrand, Inc. director equity activity: A reporting person who serves as a director of Hillenbrand, Inc. reported multiple restricted stock unit (RSU) and deferred fee awards effective 12/31/2025. Table I shows 0 shares of common stock held directly after the reported non-derivative transaction.

Table II lists a series of RSU awards labeled as deferred stock awards from 2009 through 2025, each with small additional amounts credited on 12/31/2025, such as 54 RSUs tied to a 2/11/09 grant and 80 RSUs related to deferred director fees. Each RSU represents the right to receive one share of common stock and carries dividend equivalent rights that accrue on dividend record dates.

Some RSUs vest immediately upon grant with post-service holding requirements, while others vest on the earlier of the next annual shareholder meeting or one year from grant, with accelerated vesting or share delivery tied to events such as a change in control, death, disability, or the director ceasing to serve. Certain RSUs will be automatically converted into shares when the director retires from the Board.

Rhea-AI Summary

Hillenbrand, Inc. director Gary L. Collar reported routine equity awards in the form of restricted stock units (RSUs) tied to existing deferred stock awards. On 12/31/2025, he acquired small additional RSU amounts at a price of $0 under multiple prior grant years, including 12 RSUs linked to a 2015 deferred stock award and 33 RSUs linked to a 2016 award. Each RSU represents the right to receive one share of common stock and is entitled to dividend equivalent rights that accrue on dividend record dates. Many of these RSUs vest immediately or on the earlier of the next annual shareholder meeting or one year from grant, with delivery of shares deferred until a change in control, death or disability, or after he ceases serving as a director.

Rhea-AI Summary

Hillenbrand, Inc. director equity awards and deferred fees reported

A Hillenbrand, Inc. director filed a Form 4 to report routine equity compensation and fee deferrals effective 12/31/2025. The filing shows multiple grants of restricted stock units (RSUs) tied to earlier award dates, such as “Deferred Stock Award” grants from 2010 through 2025, as well as RSUs credited from deferred director fees. Each RSU represents the contingent right to receive one share of Hillenbrand common stock and carries dividend equivalent rights that accrue on dividend record dates.

Many of these RSUs either vest immediately upon grant with post-service holding requirements, or vest on the earlier of the next annual shareholder meeting or one year from the grant date, with delivery of shares generally deferred until events such as a change in control, death, disability, or the director leaving the board. The reported positions include, for example, 6,137 RSUs from a 2011 award and 4,151 RSUs from a 2025 award, all held in direct ownership.

Rhea-AI Summary

Hillenbrand, Inc. senior vice president, general counsel and secretary Nicholas R. Farrell reported equity awards and holdings in a Form 4 dated 12/31/2025. He directly owns 74,792 shares of Hillenbrand common stock.

On that date, he acquired several zero-cost restricted stock unit (RSU) awards, including 15, 48, 51, 82 and 214 RSUs tied to prior grant dates and the company’s Executive Share Match framework. Following these awards, he holds derivative positions such as 2,240, 6,833, 7,243, 11,583 and 30,088 RSUs, each representing the contingent right to receive one share of common stock.

The RSUs have scheduled vesting dates between 12/7/2024 and 12/4/2028, and certain matching RSUs may be settled in shares or cash if specified framework conditions are satisfied. RSUs also accrue dividend equivalents on dividend record dates.

Rhea-AI Summary

Hillenbrand, Inc. reported an insider equity award for a senior executive. On 12/31/2025, Sr. VP, Strategy & Corp. Dev. J. Michael Whitted received several grants of restricted stock units (RSUs), all at a price of $0 per unit, covering different award programs and grant dates.

The new RSU awards include 17 units from a deferred stock award dated 12/7/2023, 260 units from a deferred stock award dated 6/28/2024, 39 units from a deferred stock award dated 12/5/2024, 55 and 77 matching RSUs under the Executive Share Match framework dated 03/31/2025 and 10/01/2025, and 225 units from a deferred stock award dated 12/4/2025. Each RSU represents the right to receive one share of common stock and carries dividend equivalent rights.

The RSUs vest over time, with various schedules running from 2024 through 2028, and certain matching RSUs under the Executive Share Match framework vesting in 2028. Following these transactions, Whitted directly held 88,349 shares of Hillenbrand common stock.

Rhea-AI Summary

Hillenbrand, Inc. reported insider equity activity for its Sr. VP & Chief HR Officer related to common stock and restricted stock units. The executive holds 23,512 shares of common stock directly and 16,125 shares indirectly through The Arora Revocable Trust.

On 12/31/2025, the executive acquired several blocks of restricted stock units at a price of $0 per unit, including 14 units from a deferred stock award dated 12/7/2023, 46 units from a deferred stock award dated 12/5/2024, 133 units from a Matching RSU award dated 03/31/2025, and 180 units from a deferred stock award dated 12/4/2025. These awards provide the right to receive an equal number of common shares and carry dividend equivalent rights. The various grants vest in installments between 2024 and 2028.

Rhea-AI Summary

Hillenbrand, Inc. reported an insider equity update for its interim CFO, VP, CC & CAO following transactions dated 12/31/2025. After these transactions, the officer beneficially owns 6,423 shares of Hillenbrand common stock directly.

The officer also holds several restricted stock unit (RSU) awards that each represent the right to receive one share of common stock and accrue dividend equivalents on dividend record dates. RSUs from a 12/7/2023 award are scheduled to vest in three equal parts on 12/7/2024, 12/7/2025, and 12/7/2026; RSUs from a 12/5/2024 award vest one‑third on 12/5/2025, 12/5/2026, and 12/5/2027; and RSUs from a 12/4/2025 award vest one‑third on 12/4/2026, 12/4/2027, and 12/4/2028.

Rhea-AI Summary

Hillenbrand, Inc. director Jennifer W. Rumsey reported equity awards and holdings in a Form 4 dated 12/31/2025. She indirectly holds 587 shares of common stock through The Revocable Living Trust Agreement Jennifer W. Rumsey.

She received several restricted stock unit (RSU) grants labeled as deferred stock awards, including awards dated 8/5/20, 2/11/21, 2/10/22, 2/24/23, 2/20/24, and 2/18/25, with new credited amounts of 4, 22, 20, 20, 22, and 29 RSUs, respectively, all at a price of $0. Following these transactions, her beneficially owned derivative positions include 627, 3,121, 2,882, 2,933, 3,187, and 4,151 RSUs in those respective awards.

Each RSU represents the contingent right to receive one share of common stock and carries dividend equivalent rights that accrue on dividend record dates. Certain RSUs vest immediately upon grant but are delivered only upon events such as a change in control, death, disability, or when the director ceases service, while others vest on the earlier of the next annual shareholder meeting or one year from grant, with similar delivery conditions.

Rhea-AI Summary

Hillenbrand, Inc. director reports equity award activity. A reporting person serving as a director of Hillenbrand, Inc. (ticker HI) filed details of changes in their equity holdings. On 12/31/2025, the director received 29 Restricted Stock Units as a deferred stock award, each representing the right to receive one share of common stock.

The filing states that these Restricted Stock Units carry dividend equivalent rights that accrue on dividend record dates. They vest on the earlier of Hillenbrand’s next annual meeting of shareholders or one year from the grant date, and will immediately vest upon certain events such as a change in control of the company, the director’s death or permanent and total disability, or one day after the director ceases to be a director. After this transaction, the director beneficially owns 4,151 derivative securities in the form of Restricted Stock Units held directly.

Rhea-AI Summary

Hillenbrand, Inc. reported equity holdings and awards for a senior executive. The reporting person is an officer serving as Sr. VP & President, APS, and files individually. The filing shows direct ownership of 29,508 shares of common stock.

The executive also holds several derivative securities in the form of restricted stock units (RSUs). On 12/31/2025, RSU positions were updated or acquired under multiple awards, including 20, 46, 38 and 218 RSUs, each corresponding to an equal number of Hillenbrand common shares when settled, at an exercise price of $0. Following these transactions, the executive beneficially owns derivative positions such as 2,840, 6,556, 5,386 and 30,721 RSUs, all held directly.

The RSUs generally vest in installments over future dates, including schedules with one-third vesting annually from 2024 through 2028, and a matching RSU grant under the company’s executive share match framework that is scheduled to vest on March 31, 2028, subject to vesting conditions.

Rhea-AI Summary

Hillenbrand, Inc. director reports equity awards and holdings

A director of Hillenbrand, Inc. reported equity transactions and updated ownership as of 12/31/2025. The filing shows direct ownership of 3,448 shares of common stock and additional indirect holdings through several trusts, including 20,000 shares held by the Anne Hillenbrand Singleton Trust and 135,863 shares held by Clear Water Capital Partners, LP, among others.

The director also received multiple grants of restricted stock units (RSUs) on 12/31/2025, such as awards originally granted on dates from May 2018 through February 2025, with small incremental amounts ranging from 7 to 31 units per award and an exercise price of $0. Each RSU represents the right to receive one share of common stock and carries dividend equivalent rights. The RSUs vest either immediately or on the earlier of the next annual shareholder meeting or one year from grant, with accelerated vesting upon certain events like a change in control, death, disability, or when the director ceases to serve.

Rhea-AI Summary

Hillenbrand, Inc. insider equity update: A senior executive, identified as an officer serving as Sr. VP & President, MTS, reported equity holdings and new deferred equity awards in a Form 4 filing. Following the reported activity, the executive directly beneficially owns 8,903 shares of Hillenbrand common stock.

The filing details several grants of restricted stock units (RSUs) effective 12/31/2025, including deferred stock awards of 61, 17, 53 and 241 RSUs, and Matching RSUs of 8 and 16 units, all with a $0 exercise price. Each RSU represents the contingent right to receive one share of common stock and carries dividend equivalent rights. The awards vest in tranches between 2024 and 2028 under scheduled vesting dates and the company’s Executive Share Match framework, with settlement in shares or cash depending on vesting conditions.

Rhea-AI Summary

Hillenbrand, Inc. reported insider equity activity by its Sr. VP & Chief Information Officer. On 12/31/2025, the officer acquired 182 shares of common stock at $0 through the vesting and settlement of previously granted restricted stock units, increasing direct holdings to 15,678 shares. On the same date, 81 shares were disposed of at $31.745 in a transaction coded “F,” typically used for shares withheld or sold to cover taxes, leaving 15,597 common shares directly owned.

The filing also lists multiple restricted stock unit awards and matching RSUs that each convert into one share of common stock, with vesting schedules running from 2024 through 2028 and entitlement to dividend equivalent rights that accrue on dividend record dates. Several RSU grants were credited on 12/31/2025, and one prior RSU award was partially settled into 182 common shares while retaining a remaining RSU balance.

Rhea-AI Summary

Hillenbrand, Inc. reported equity awards to its President and CEO, Kimberly K. Ryan, as of 12/31/2025. The filing shows she directly beneficially owns 208,945.745 shares of Hillenbrand common stock.

The CEO also acquired several blocks of restricted stock units (RSUs) at a price of $0, including deferred stock awards dated 12/7/2023, 12/5/2024, and 12/4/2025, and Matching RSUs granted under the company’s Executive Share Match framework dated 03/31/2025. Each RSU represents the contingent right to receive one share of common stock and carries dividend equivalent rights that accrue on dividend record dates.

The RSUs vest in installments: some vest one-third per year on specific December dates from 2024 through 2028, while the Matching RSUs are scheduled to vest on March 31, 2028, subject to the framework’s vesting conditions and may be settled in shares or cash.

Rhea-AI Summary

Hillenbrand, Inc. director Dennis W. Pullin reported changes in his equity holdings as of 12/31/2025. Table I shows he held zero shares of common stock directly after the reported transactions, while Table II details multiple grants of restricted stock units (RSUs) tied to prior deferred stock awards from 2021 through 2025. The RSUs were credited at a price of $0 per unit, reflecting non-cash awards.

Each RSU represents the right to receive one share of Hillenbrand common stock and carries dividend equivalent rights that accrue on dividend record dates. These RSUs vest at the earlier of the next annual shareholder meeting or one year from grant, with accelerated vesting and share delivery upon a change in control, the director’s death or permanent disability, or shortly after the director leaves the board.

Rhea-AI Summary

Hillenbrand, Inc. reported equity awards for director Joy M. Greenway. On 12/31/2025, multiple tranches of restricted stock units (RSUs) tied to prior deferred stock awards from 2013 through 2025 were credited to her account at an exercise price of $0.

Each RSU represents the right to receive one share of Hillenbrand common stock and carries dividend equivalent rights that accrue on dividend record dates. Some of these RSUs vest immediately upon grant, while others vest on the earlier of the next annual shareholder meeting or one year from grant, with accelerated vesting upon events such as a change in control, death, disability, or when the director ceases to serve.

Following these transactions, Greenway continues to hold the RSUs directly as a director of the company, reflecting ongoing equity-based compensation rather than open-market purchases or sales of common shares.

Rhea-AI Summary

Hillenbrand, Inc. director reports new stock-based awards. The filing shows director Helen W. Cornell reporting multiple grants of restricted stock units as deferred stock awards dated 12/31/2025, each representing the right to receive one share of Hillenbrand common stock at an exercise price of $0.

The restricted stock units carry dividend equivalent rights that accrue on dividend record dates. Some awards vest immediately upon grant but require the director to hold the underlying shares for a period after leaving the board, while others vest on the earlier of the next annual shareholder meeting or one year from grant, with share delivery tied to events such as a change in control, death, disability, or the director ceasing to serve.

The filing also shows indirect ownership of Hillenbrand common stock held through the Helen W. Cornell 2020 Irrevocable Trust and the Helen W. Cornell Revocable Trust.

Rhea-AI Summary

Hillenbrand, Inc. officer equity holdings and awards are reported for an individual serving as Sr. VP & Chief Proc. Officer. As of this filing, the officer directly holds 6,949 shares of common stock.

The filing shows several restricted stock unit (RSU) awards effective on 12/31/2025, each with a conversion price of $0 and each RSU representing the right to receive one share of common stock. RSUs from prior grant dates in 2023, 2024 and 2025 are scheduled to vest in one-third installments on specific December dates, while Matching RSUs granted under the company’s Executive Share Match framework are scheduled to vest on March 31, 2028 if framework conditions are met. RSUs carry dividend equivalent rights that accrue on dividend record dates.

Rhea-AI Summary

Hillenbrand, Inc. reported an insider equity transaction involving director Inderpreet Sawhney dated 12/31/2025. The filing shows multiple grants of restricted stock units (RSUs) under deferred stock award programs, each RSU representing the right to receive one share of Hillenbrand common stock.

The RSU awards listed include 6, 20, 20, 22 and 29 units tied to grant dates in 2021, 2022, 2023, 2024 and 2025, all with a price of $0, reflecting that these are equity awards rather than open-market purchases. Following these transactions, Sawhney beneficially owns derivative securities in the form of RSUs in amounts of 874, 2,882, 2,933, 3,187 and 4,151 units across the respective awards, all held directly.

The RSUs vest upon the earlier of Hillenbrand’s next annual meeting of shareholders or one year from the date of grant, with accelerated vesting and share delivery linked to events such as a change in control, the director’s death or permanent and total disability, or one day after the director ceases to serve on the board. The awards also carry dividend equivalent rights that accrue on dividend record dates.

Rhea-AI Summary

Hillenbrand, Inc. senior vice president of strategy and corporate development J. Michael Whitted reported multiple equity transactions involving company common stock. On 12/05/2025 and 12/07/2025, restricted stock units (RSUs) vested and were settled into a total of 6,852 shares of common stock at an exercise price of $0, reflecting the conversion of deferred stock awards granted in 2022, 2023, and 2024. On both dates, the company withheld a total of 2,008 shares at a price of $31.82 per share to cover tax obligations, reported as dispositions. After these transactions, Whitted directly owned 88,349 shares of Hillenbrand common stock. RSUs from the 2022, 2023, and 2024 awards vest in three equal annual installments on specified December dates.

Rhea-AI Summary

Hillenbrand, Inc. reported insider equity activity by President & CEO Kimberly K. Ryan. On 12/05/2025, 17,475 shares of common stock were acquired at $0 upon settlement of restricted stock units, with 7,817 shares disposed of at $31.82 per share, typically reflecting shares withheld for taxes. On 12/07/2025, a further 24,516 shares were acquired at $0, and 10,967 shares were disposed of at $31.82.

After these transactions, Ryan directly beneficially owned 208,945.745 shares of common stock. Derivative holdings show restricted stock units tied to prior awards, including 14,400 units from a 12/7/2023 award and 17,475 units from a 12/5/2024 award, which vest in one-third installments on specified future dates.

Rhea-AI Summary

Hillenbrand, Inc. reported equity transactions by a senior vice president and President of MTS, filed on Form 4. On 12/05/2025 and 12/07/2025, the officer acquired common stock through the vesting and settlement of restricted stock units, with transactions coded "M" at a price of $0 per share. On the same dates, the officer disposed of 1,756 and 1,116 shares of common stock, respectively, at $31.82 per share in transactions coded "F," which typically reflect share withholding to cover taxes. After these transactions, the officer directly held 8,903 shares of common stock and 7,471 restricted stock units that each represent the right to receive one share of common stock.

Rhea-AI Summary

Hillenbrand, Inc. reported insider equity transactions by Interim CFO, VP, CC, & CAO Megan A. Walke. On 12/05/2025 and 12/07/2025, restricted stock units (RSUs) granted in prior years converted into common stock at an exercise price of $0, reflecting scheduled vesting of deferred stock awards. In connection with these vestings, a total of 1,150 shares of common stock were withheld and disposed of at $31.82 per share to cover tax obligations, coded as transaction type “F.” Following the reported transactions, Walke directly owned 6,423 shares of Hillenbrand common stock. The RSU awards continue to vest in one-third installments on specified dates through 12/07/2027.

Rhea-AI Summary

Hillenbrand, Inc. reported insider equity activity by Senior Vice President and Chief Procurement Officer Carole Anne Phillips. On 12/05/2025, 940 shares of common stock were acquired at $0 upon the vesting of restricted stock units, and 410 shares were withheld at $31.82 per share, leaving 6,165 shares of common stock directly owned.

On 12/07/2025, an additional 1,393 shares were acquired at $0 from vesting restricted stock units, and 609 shares were withheld at $31.82 per share, resulting in 6,949 shares of common stock directly owned. The derivative table shows multiple restricted stock unit awards converting into common stock, with remaining restricted stock unit balances of 814 and 1,884 units under two grants.

Rhea-AI Summary

Hillenbrand, Inc. reported insider equity transactions by senior executive Bhavik N. Soni, Sr. VP & Chief Information Officer. On December 5, 2025 and December 7, 2025, previously granted restricted stock units (RSUs) converted into common stock at an exercise price of $0, and some of the resulting shares were withheld at $31.82 per share, typically to cover tax obligations. After these transactions, Soni directly beneficially owned 15,496 shares of Hillenbrand common stock.

The RSUs stem from deferred stock awards granted in 2022, 2023, and 2024, each scheduled to vest in three annual installments on specific December dates through 2027. Each RSU represents the right to receive one share of common stock and carries dividend equivalent rights that accrue on dividend record dates.

Rhea-AI Summary

Hillenbrand, Inc. reported insider equity transactions by its Sr. VP & Chief HR Officer, who filed a Form 4 for activity in early December 2025. On 12/05/2025 and 12/07/2025, restricted stock units (RSUs) converted into common stock, with 3,220 and 3,512 shares acquired at an exercise price of $0 under transaction code M. On those same dates, 1,408 and 1,535 shares of common stock were disposed of at $31.82 per share under transaction code F. After these transactions, the officer directly owned 23,512 shares of Hillenbrand common stock and indirectly held 16,125 shares through The Arora Revocable Trust. The RSUs relate to deferred stock awards originally granted in 2022, 2023, and 2024, which vest in three annual installments through 2027.

Rhea-AI Summary

Hillenbrand, Inc. executive reports stock and RSU transactions. A senior vice president, general counsel and secretary filed a Form 4 reporting vesting of restricted stock units and related share withholding for taxes. On 12/05/2025, 3,389 shares of common stock were acquired at $0 upon RSU conversion, and 1,453 shares were disposed of at $31.82. On 12/07/2025, 3,734 shares were acquired at $0 from additional RSU vesting, and 1,601 shares were disposed of at $31.82. After these transactions, the reporting person directly owned 74,792 shares of common stock and continued to hold multiple restricted stock unit awards that vest in annual installments through 2027.

Rhea-AI Summary

Hillenbrand, Inc. officer reports stock and RSU activity. Senior Vice President & President, APS, Bartel Ulrich reported multiple transactions in company common stock on 12/05/2025 and 12/07/2025. Restricted Stock Units converted into common shares at $0, including 3,253 shares on 12/05/2025 and 4,676 shares on 12/07/2025, reflecting scheduled vesting.

To cover related obligations, 1,677 shares were disposed of at $31.82 on 12/05/2025 and 2,410 shares at $31.82 on 12/07/2025. After these transactions, Ulrich directly owned 29,508 shares of common stock and held derivative awards including 2,820 Restricted Stock Units from a 2023 award and 6,510 Restricted Stock Units from a 2024 award, each unit representing the right to receive one share of common stock with scheduled vesting over three years.

Rhea-AI Summary

Hillenbrand, Inc. reported insider equity activity by Sr. VP & Chief HR Officer Aneesha Arora. On 12/05/2025, she acquired 2,492 shares of common stock at $31.82 per share through the vesting of performance-based restricted stock units, then disposed of 1,089 shares at $31.82 to cover obligations. After these transactions, she directly owned 19,723 common shares and indirectly owned 16,125 shares through The Arora Revocable Trust.

Separately, on 12/04/2025, she received a new award of 25,157 restricted stock units, each representing the right to receive one share of common stock. These units carry dividend equivalent rights and are scheduled to vest in three equal installments on 12/04/2026, 12/04/2027, and 12/04/2028.